Skip to contentClarengateINTELLIGENCE
Companies/SC558719

Adorx Therapeutics Limited

Research and experimental development on biotechnology · Edinburgh

ActiveUnited KingdomIncorporated 2017Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-02-28 · GBP · unknown scope

Net assets
Cash
£4,886,329
Turnover
Profit / loss
£211,002
Current assets
£4,967,039
Creditors < 1 year
£106,694
Equity
£4,860,345
Average employees
0

Balance-sheet trend

GBP · unknown

Two periods with a known, matching scope are needed for a trend.

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

3 periods
Reported figures2025-02-28GBP · unknown2024-02-28GBP · unknown2023-02-28GBP · unknown
Balance sheet
Equity£4,860,345£7,849,343£10,703,895
Assets
Current assets£4,967,039£9,215,415
Cash at bank£4,886,329£5,435,944
Debtors£80,710£3,779,471
Liabilities
Creditors within one year£106,694£1,366,072
Net current assets£4,860,345£7,849,343
Profit & loss
Profit before tax£89,415£11,971,761
Profit / loss£211,002£13,145,448
People
Average employees0
Source evidenceView filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges
Show 1 satisfied / released
All Assets · created 2018-01-22 · satisfied 2018-03-19
Satisfied